
Lupin Limited has informed the Exchange regarding a press release dated Jun 14, 2024, titled "Lupin Announces Closure of US FDA Inspection at its Injectable Facilitywith Zero 483 Observations".
Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated Jun 14, 2024, titled "Lupin Announces Closure of US FDA Inspection at its Injectable Facilitywith Zero 483 Observations".
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin